HUE050456T2 - Dimetil-amino-mikeliolid tüdõfibrózis kezelésében történõ alkalmazásra - Google Patents

Dimetil-amino-mikeliolid tüdõfibrózis kezelésében történõ alkalmazásra

Info

Publication number
HUE050456T2
HUE050456T2 HUE16887050A HUE16887050A HUE050456T2 HU E050456 T2 HUE050456 T2 HU E050456T2 HU E16887050 A HUE16887050 A HU E16887050A HU E16887050 A HUE16887050 A HU E16887050A HU E050456 T2 HUE050456 T2 HU E050456T2
Authority
HU
Hungary
Prior art keywords
dimethylaminomicheliolide
treatment
pulmonary fibrosis
fibrosis
pulmonary
Prior art date
Application number
HUE16887050A
Other languages
English (en)
Inventor
Tao Sun
Yue Chen
Cheng Yang
Honggang Zhou
Huijuan Liu
Yanrong Liu
Jing Wang
Chengyu Zhang
Qiang Zhang
Xiangming Zhang
Yuan Qin
Xueshuang Jing
Original Assignee
Accendatech
Tianjin Int Joint Academy Of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accendatech, Tianjin Int Joint Academy Of filed Critical Accendatech
Publication of HUE050456T2 publication Critical patent/HUE050456T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUE16887050A 2016-01-28 2016-01-28 Dimetil-amino-mikeliolid tüdõfibrózis kezelésében történõ alkalmazásra HUE050456T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2016/072445 WO2017128163A1 (zh) 2016-01-28 2016-01-28 含笑内酯二甲基胺的应用
EP16887050.9A EP3320901B1 (en) 2016-01-28 2016-01-28 Dimethylaminomicheliolide for use in the treatment of pulmonary fibrosis

Publications (1)

Publication Number Publication Date
HUE050456T2 true HUE050456T2 (hu) 2020-12-28

Family

ID=59397048

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16887050A HUE050456T2 (hu) 2016-01-28 2016-01-28 Dimetil-amino-mikeliolid tüdõfibrózis kezelésében történõ alkalmazásra

Country Status (12)

Country Link
US (1) US10220019B2 (hu)
EP (1) EP3320901B1 (hu)
JP (1) JP6642892B2 (hu)
AU (1) AU2016390488B9 (hu)
CA (1) CA2995132C (hu)
DK (1) DK3320901T3 (hu)
ES (1) ES2783879T3 (hu)
HR (1) HRP20200473T1 (hu)
HU (1) HUE050456T2 (hu)
PL (1) PL3320901T3 (hu)
PT (1) PT3320901T (hu)
WO (1) WO2017128163A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11634400B2 (en) 2017-08-19 2023-04-25 University Of Rochester Micheliolide derivatives, methods for their preparation and their use as anticancer and antiinflammatory agents
JP2023522792A (ja) * 2020-03-26 2023-05-31 天津尚徳薬縁科技股▲フン▼有限公司 ジメチルアミノミケリオリドフマル酸塩水和物、その調製方法及び用途
WO2022041123A1 (zh) * 2020-08-28 2022-03-03 洛阳尚德药缘科技有限公司 倍半萜内酯类化合物在制备治疗视神经炎药物上的应用
CN113200949B (zh) * 2021-04-16 2022-11-29 天津大学 一种二甲胺含笑内酯-水杨酸盐及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA00011713A (es) * 2000-11-28 2002-05-31 Tgt Lab S A De C V Vectores recombinantes virales y no virales conteniendo el gen humano del activador de plasminogeno derivado de urocinasa y su utilidad en el tratamiento de diversos tipos de fibrosis hepatica, renal, pulmonar, pancreatica, cardiaca y cicatrices hipe
DK2562172T3 (en) * 2010-04-23 2016-06-20 Accendatech Sphaelactonderivater, pharmaceutical compositions thereof, methods of preparation and uses
CA2817975C (en) * 2010-11-16 2020-03-31 Michael Kahn Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
US10463644B2 (en) * 2013-07-15 2019-11-05 Accendatech Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation
CN104418744B (zh) * 2013-08-29 2017-03-01 天士力制药集团股份有限公司 一种新的丹酚酸化合物t、其制备方法和用途
CN104876899A (zh) * 2014-02-28 2015-09-02 天津尚德药缘科技股份有限公司 二甲胺含笑内酯富马酸盐及其用途
CN105520933B (zh) * 2014-09-29 2020-05-12 天津国际生物医药联合研究院 含笑内酯二甲基胺的应用

Also Published As

Publication number Publication date
EP3320901B1 (en) 2020-03-04
CA2995132A1 (en) 2017-08-03
DK3320901T3 (da) 2020-05-11
JP6642892B2 (ja) 2020-02-12
AU2016390488B9 (en) 2020-09-17
WO2017128163A1 (zh) 2017-08-03
AU2016390488B2 (en) 2019-12-12
JP2019503335A (ja) 2019-02-07
EP3320901A4 (en) 2018-11-14
US20190000798A1 (en) 2019-01-03
CA2995132C (en) 2020-04-21
PL3320901T3 (pl) 2020-07-13
PT3320901T (pt) 2020-04-24
US10220019B2 (en) 2019-03-05
ES2783879T3 (es) 2020-09-18
AU2016390488A1 (en) 2018-03-01
EP3320901A1 (en) 2018-05-16
HRP20200473T1 (hr) 2020-10-02

Similar Documents

Publication Publication Date Title
HK1258396A1 (zh) 用於治療纖維化的賽尼克韋羅聯合療法
HK1232147A1 (zh) 用於治療纖維化的賽尼克韋羅
IL250960B (en) Combined treatment of sinecriviroc for the treatment of leprosy
IL247841A0 (en) Heterocyclic compounds for use in the treatment of disorders mediated by pi3k gamma
EP3204007C0 (en) TRIAZOLOPYRIDINE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
IL266530B1 (en) Use of Amcol for the treatment of fibrosis
IL251904A0 (en) Epilimod for use in the treatment of melanoma
IL250980A0 (en) Mucolytic agents for use in the treatment of pulmonary sarcoidosis
IL263804A (en) Wnt inhibitors for use in the treatment of fibrosis
SG11201607461PA (en) Polishing composition and polishing method using the same
PT3160464T (pt) 6-hidroxibuspirona para uso no tratamento de transtornos do movimento
HK1247558A1 (zh) 塞內可瑞偉洛克(cenicriviroc)用於治療纖維化
IL246855A0 (en) Materials for use in the treatment of retinitis
PL3320901T3 (pl) Dimetyloaminomicheliolid do zastosowania w leczeniu włóknienia płuc
IL251840A0 (en) Use of femiroplast in the treatment of severe asthma
ZA201901099B (en) Compositions for the treatment of pulmonary fibrosis
HK1217913A1 (zh) 阿地米屈在治療上皮功能障礙中的用途
PL3020794T3 (pl) Kompozycja środka piorącego i jej zastosowanie
PL3439645T3 (pl) Stosowanie tamoksyfenu w leczeniu mukowiscydozy u pacjentów płci innej niż żeńska
ZA201408464B (en) Composition for the use in treatment of asthma
GB201511772D0 (en) Improvements in the treatment of ash
GB201418305D0 (en) Treatment for Idiopathic pulmonary fibrosis
GB201418303D0 (en) Treatment for Idopathic pulmonary Fibrosis